If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
5
Followers on Owler
Tessa Therapeutics
is a biotechnology company that researches and develops cell-based immunotherapies for the treatment of cancer...
Read more
Overview
Competitors
Acquisitions
Funding
News & Insights
Tessa Therapeutics
is a biotechnology company that researches and develops cell-based immunotherapies for the treatment of cancer...
Read more
CEO
Jeffrey H. Buchalter
CEO Approval Rating
90/100
Weigh In
2011
Singapore
Central Singapore
Private
Pharmaceuticals & Biotechnology
Biotechnology
Pharmaceuticals
2836
2834
NAICS listing
http://www.tessatherapeutics.com
Est. Annual Revenue
$25-100M
Agree?
Yes
No
Est. Employees
100-250
Agree?
Yes
No
Funding
$130M
Acquisitions
1
News
Latest News
Dec 17, 2020
Medical Device News Magazine
Tessa Therapeutics: David McIntyre Is Appointed CFO of Tessa Therapeutics: Expert Provides 25 Years + of Global, Operational, and Legal Experience
Aug 06, 2020
FinanzNachrichten
Tessa Therapeutics: Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma
May 05, 2020
Biospectrum Asia
Tessa Therapeutics: Tessa Therapeutics Announces New Executive Leadership
May 04, 2020
FinanzNachrichten
Tessa Therapeutics: Tessa Therapeutics Announces New Executive Leadership
Mar 17, 2020
The Pharma Letter
Tessa Therapeutics: Tessa's CAR-T therapy set to lead the way in Hodgkin's lymphoma, says GlobalData
Mar 02, 2020
Biospectrum Asia
Tessa Therapeutics: Tessa Therapeutics CD30 CAR-T cell therapy attains USFDA RMAT designation, Read more
Mar 02, 2020
Biospectrum Asia
Tessa Therapeutics: Tessa Therapeutics CD30 CAR-T cell therapy attains USFDA RMAT designation
Dec 20, 2019
FiercePharma
Tessa Therapeutics: Tessa Therapeutics to build commercial-scale facility for VST therapies
Dec 20, 2019
Biospectrum Asia
Tessa Therapeutics: Tessa Therapeutics to open manufacturing unit in Singapore
Jun 15, 2019
Pharmabiz
Tessa Therapeutics: Tessa Therapeutics, CSGKC establish US$120 million JV in China to develop innovative cell therapies for cancer
Follow and Get Alerts
Tessa Therapeutics Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 11 + competitors
Trending Companies